FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended March 31, 1998


Commission File Number 1-8635


         New York                                                     11-2571221
(State or other jurisdiction of                                 (I.R.S. Employer
incorporation or organization)                            Identification Number)

                    3265Lawson Boulevard, Oceanside, New York
                 11572 (Address of principal executive offices)
                                   (Zip Code)

                                 (516) 536-5850
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes [X]    No [_]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest  practicable  date:  5,890,950 shares of $.01 par
value common stock as of May 4, 1998.



<PAGE>



                          AMERICAN MEDICAL ALERT CORP.




                                     INDEX                                  PAGE

Part  I  Financial Information

              Condensed Balance Sheets for March 31, 1998
              and December 31, 1997                                           1

              Condensed Statements of Income for the
              Three Months Ended March 31, 1998 and 1997                      2

              Condensed Statements of Cash Flows for
              the Three Months Ended March 31, 1998 and 1997                 3-4

              Notes to Condensed Financial Statements                         5

              Management's Discussion and Analysis of
              Financial Condition and Results of Operations                   6

Part II  Other Information                                                    7





<PAGE>





ITEM 1. FINANCIAL STATEMENTS.

                          AMERICAN MEDICAL ALERT CORP.
                            CONDENSED BALANCE SHEETS

                                     ASSETS
<TABLE>
<CAPTION>
                                                                        March 31, 1998    Dec. 31, 
                                                                         (UNAUDITED)        1997*
                                                                         -----------    -----------
<S>                                                                      <C>            <C>
CURRENT ASSETS:
        Cash                                                             $   448,468    $   304,739
        Accounts and notes receivable
        (net of allowance for doubtful accounts of $40,000 in
          '98 & $30,000 in '97)                                            1,784,634      1,574,738
        Inventory                                                          1,270,800      1,310,551
        Prepaid expenses and other current assets                            175,290        196,990
        Deferred income tax benefit                                           93,000         97,000
                                                                         -----------    -----------

        Total Current Assets                                             $ 3,772,192    $ 3,484,018

FIXED ASSETS:
        (Net of accumulated depreciation and amortization)                 4,005,080      3,732,849

OTHER ASSETS                                                                 236,687         34,761
                                                                         -----------    -----------

TOTAL ASSETS                                                             $ 8,013,959    $ 7,251,628
                                                                         ===========    ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
        Note payable - bank                                              $      --      $   150,000
        Accounts payable                                                     316,188        161,795
        Accrued expenses                                                     207,223        139,802
        Taxes payable                                                        126,334           --
        Current portion of  deferred income                                    4,700           --
        Current portion of long-term debt                                     59,532          9,056
                                                                         -----------    -----------
        Total Current Liabilities                                            713,977        460,653
                                                                         -----------    -----------

DEFERRED INCOME TAX LIABILITY                                                318,000        318,000
DEFERRED INCOME                                                               23,666           --
LONG-TERM DEBT - LESS CURRENT MATURITIES                                     186,968          2,797
                                                                         -----------    -----------
        Total Liabilities                                                  1,242,611        781,450
                                                                         -----------    -----------
COMMITMENTS AND CONTINGENT LIABILITIES

SHAREHOLDERS' EQUITY
        Common stock - $.01 par value; authorized - 10,000,000 shares;
        issued - 5,928,309 shares in 1998                                     59,283         59,045
        and 5,904,607 shares in 1997                                       4,568,875      4,523,189
        Additional paid-in capital                                         2,249,222      1,993,976
                                                                         -----------    -----------
        Retained Earnings                                                  6,877,380      6,576,210

        Less 43,910 shares in 1998 & 1997 of treasury stock, at cost        (106,032)      (106,032)
                                                                         -----------    -----------
        Total Shareholders' Equity                                         6,771,348      6,470,178
                                                                         -----------    -----------

TOTAL LIABILITIES AND SHAREHOLDERS'  EQUITY                              $ 8,013,959    $ 7,251,628
                                                                         ===========    ===========
</TABLE>


See accompanying notes to condensed financial statements.
* Derived from audited financial statements.



334749-1
                                                           1

<PAGE>



                          AMERICAN MEDICAL ALERT CORP.

                         CONDENSED STATEMENTS OF INCOME
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                Three months Ended March 31,
                                                                    1998           1997
                                                                -----------    -----------
<S>                                                             <C>            <C>        
Revenues:
        Services                                                $ 1,822,425    $ 1,615,765
        Product sales                                               221,257        114,575
                                                                -----------    -----------
                                                                  2,043,682      1,730,340

Costs  and Expenses (Income):
        Costs related to services                                   662,104        591,292
        Costs of products sold                                      161,197        107,399
        Selling, general and administrative expenses                751,213        704,818
        Interest expense                                              6,548         12,830
        Other income                                                   (626)          (346)
                                                                -----------    -----------

Income before provision for income taxes                            463,246        314,347

Provision for income taxes                                          208,000        139,000
                                                                -----------    -----------


NET INCOME                                                      $   255,246    $   175,347
                                                                ===========    ===========

Net income per share:
        Basic                                                   $       .04    $       .03
                                                                -----------    -----------

        Diluted                                                 $       .04    $       .03
                                                                -----------    -----------

Weighted average number of common shares outstanding (Note 3)
        Basic                                                     5,871,715      5,804,674
                                                                ===========    ===========

        Diluted                                                   5,931,089      5,848,584
                                                                ===========    ===========
</TABLE>

See accompanying notes to condensed financial statements.


                                        2

<PAGE>



                          AMERICAN MEDICAL ALERT CORP.

                       CONDENSED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                    Three Months Ended March 31,
                                                          1998         1997
                                                       ---------    ---------
<S>                                                    <C>          <C>      
Cash Flows From Operating Activities:

        Net Income                                     $ 255,246    $ 175,346

        Adjustments to reconcile net income to
           net cash provided by operating activities
        Provision for bad debts                           10,000         --
        Depreciation and amortization                    224,514      171,144
        Loss on unrecovered leased medical equipment      21,675       22,246
        Change in Assets and Liabilities:
        (Increase) in receivables                       (219,896)      (1,092)
        Decrease in inventory                             39,751        9,725
        (Increase) Decrease in prepaid expenses
           and other assets                               (1,226)      38,556
        (Increase) Decrease in accounts payable,
           accrued expenses and taxes payable            348,148     (141,106)
                                                       ---------    ---------

Net Cash Provided by Operating Activities                678,212      274,819
                                                       ---------    ---------

Cash Flows from Investing Activities:
        Net expenditures for fixed assets               (618,773)    (204,817)
        Payment for account acquisitions                (175,000)        --
                                                       ---------    ---------

Net Cash (Used In) Investing Activities                 (793,773)    (204,817)
                                                       ---------    ---------

Cash Flows from Financing Activities:
        Increase (Decrease) in loans payable              84,647       (2,194)
        Net Proceeds upon exercise of stock options       45,924       22,581
        Sale/leaseback of equipment                      128,719         --
                                                       ---------    ---------


Net Cash Provided by Financing Activities                258,290       20,387
                                                       ---------    ---------
</TABLE>

See accompanying notes to condensed financial statements.


                                        3

<PAGE>



                          AMERICAN MEDICAL ALERT CORP.

                 CONDENSED STATEMENTS OF CASH FLOWS (Continued)

                                   (Unaudited)





                                                 Three Months Ended March 31,
                                                       1998       1997
                                                    --------   --------

        Net Increase (Decrease)  in Cash            $143,729   $ 90,389

        Cash, Beginning of Period                    304,739    301,013
                                                    --------   --------


        Cash, End of Period                         $448,468   $391,402
                                                    ========   ========


SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:



CASH PAID DURING THE PERIOD
FOR INTEREST                                        $  6,548   $ 12,830
                                                    ========   ========


CASH PAID DURING THE PERIOD
FOR INCOME TAXES                                    $ 45,659   $108,727
                                                    ========   ========










See accompanying notes to condensed financial statements.









                                        4

<PAGE>




                          AMERICAN MEDICAL ALERT CORP.

                     Notes to Condensed Financial Statements
                                   (Unaudited)


1.  General:

    These financial  statements should be read in conjunction with the financial
    statements  and notes thereto for the year ended  December 31, 1997 included
    in the Company's Annual Report on Form 10-KSB.

2.  Results of Operations:

    In the opinion of management, the accompanying unaudited condensed financial
    statements  contain all  adjustments  (consisting  only of normal  recurring
    accruals) necessary to present fairly the financial position as of March 31,
    1998,  and the results of operations  and of cash flows for the three months
    ended March 31, 1998 and 1997.

    The accounting policies used in preparing these financial statements are the
    same as those described in the December 31, 1997 financial statements.

    The results of operations  for the three months ended March 31, 1998 are not
    necessarily  indicative  of the results to be expected for any other interim
    period or for the full year.

3.  Income Per Share:

    In February 1997, the Financial  Accounting Standards Board issued Statement
    of Financial  Accounting  Standards  ("SFAS") No.128,  "Earnings per Share,"
    which changes the methodology of calculating earnings per share. SFAS No.128
    requires the  disclosure  of diluted  earnings per share  regardless  of its
    difference  from basic earnings per share.  The Company adopted SFAS No. 128
    in December  1997.  Earnings per share data for the three months ended March
    31, 1997 have been stated to conform with this pronouncement.








                                        5

<PAGE>



Item 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS.

The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the consolidated  financial  statements contained in the latest
Annual Report dated December 31, 1997.

This  discussion  contains  forward-looking  statements  which,  in  addition to
assuming a  continuation  of the degree and timing of customer  utilization  and
rate of renewals of contracts with the Company at historical levels, are subject
to a number of known and unknown  risks that,  in addition to general  economic,
competitive  and  other  business   conditions,   could  cause  actual  results,
performance  and  achievements  to differ  materially  from those  described  or
implied in the forward-looking statements.

LIQUIDITY AND CAPITAL RESOURCES

On April 27, 1998, the Company negotiated a $2,000,000 Revolving Credit Facility
with a  bank  (based  upon  75%  of  eligible  accounts  receivable  and  25% of
inventory,  as defined)  expiring May 31, 2000.  The note bears  interest at the
lower of prime rate or LIBOR Rate plus 2.50 % (as defined) and is collateralized
by the  Company's  assets.  There are no  amounts  outstanding  under the Credit
Facility as of May 4, 1998. The agreement  provides for negative and affirmative
covenants  including  those related to tangible net worth,  working  capital and
other borrowings.

During 1998, the Company  anticipates  that it will make capital  investments of
approximately  $1,500,000  of which  approximately  $430,000  has been  expended
through March 31, 1998 for the purchase and production of additional systems the
Company  intends to rent. In addition,  approximately  $80,000 has been expended
for the  purchase  of office and  computer  equipment  used in  operations.  The
Company has also entered into a sale/leaseback agreement for equipment.

The Company  believes that its present cash and working  capital  position,  its
borrowing  availability and future anticipated income will be sufficient to meet
its cash and working capital needs for the foreseeable future.

RESULTS OF OPERATIONS

Revenue from  services  increased  $206,660 for the three months ended March 31,
1998 as compared to the same period in 1997,  an increase of 13%.  This increase
resulted from  expansion of the Company's  customer base for monthly  monitoring
and leasing services. Costs related to services for the three months ended March
31, 1998 and 1997 were 36% and 37%, respectively.

Revenue from product sales  increased  $106,682 for the three months ended March
31,  1998 as  compared  to the same  period in 1997,  a  increase  of 93%.  This
increase  was  primarily  due to the  increase  in sales of our new Model 700 to
distributors  and sales to retirement  communities.  The gross profit on product
sales for the three months ended March 31, 1998 and 1997 was 27% and 6%,


                                        6

<PAGE>



respectively.  Gross  profit  increased  as a  result  of lower  production  and
overhead costs.

Interest  expense for the three  months ended March 31, 1998 and 1997 was $6,548
and  $12,830,  respectively.  Selling,  general and  administrative  expenses as
compared as a percentage of total  revenues for the three months ended March 31,
1998  and  1997  were  37% and 31%  respectively.  The  decrease  in  costs as a
percentage of total revenue in 1998 was due to greater operating efficiencies.


                           PART II - OTHER INFORMATION



Item 6. EXHIBIT AND REPORTS ON FORM 8-K.


(a)  Exhibits:

      27.  Financial Data Schedule


(b) Reports on Form 8-K:

      No reports on Form 8-K were filed.



                                        7

<PAGE>


                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly  caused  this  report  to be signed  on its  behalf by the  undersigned
thereunto duly authorized.





                                                AMERICAN MEDICAL ALERT CORP.


Dated:  May 5, 1998                             By: /S/ HOWARD M. SIEGEL
                                                    ------------------------
                                                    Howard M. Siegel
                                                    President & Chief Operating 
                                                       Officer



                                                By: /S/ COREY M. ARONIN
                                                    ------------------------
                                                    Corey M. Aronin
                                                    Chief Financial Officer